Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The RECLAIM Study.

NCT: NCT06450444 · RECRUITING

NCT IDNCT06450444
StatusRECRUITING
Start Date2024-06-24
Completion2029-01-31
SponsorSalvia BioElectronics (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑